Medicenna Therapeutics Corp. (MDNAF)

Medicenna Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	24.84	16.98	33.6	20.54	30.38
Trading Asset Securities	-	-	-	-	10.01
Cash & Short-Term Investments	24.84	16.98	33.6	20.54	40.39
Cash Growth	46.26%	-49.45%	63.60%	-49.15%	7.12%
Other Receivables	2.7	1.16	0.86	1.31	0.41
Receivables	2.7	1.16	0.86	1.31	0.41
Prepaid Expenses	0.64	0.93	1.93	1.55	1.35
Total Current Assets	28.17	19.08	36.39	23.39	42.15
Property, Plant & Equipment	0.16	-	-	-	0.03
Other Intangible Assets	0.05	0.06	0.06	0.07	0.07
Total Assets	28.38	19.13	36.45	23.46	42.25
Accounts Payable	2.7	2.07	1.62	1.67	2.25
Accrued Expenses	1.69	0.79	2.18	0.95	1.83
Current Portion of Leases	0.05	-	-	-	0.03
Other Current Liabilities	-	-	3.16	-	-
Total Current Liabilities	4.44	2.86	6.96	2.62	4.11
Long-Term Leases	0.12	-	-	-	-
Other Long-Term Liabilities	4.73	11.08	-	-	-
Total Liabilities	9.29	13.94	6.96	2.62	4.11
Common Stock	116.3	100.92	100.92	83.67	79.59
Additional Paid-In Capital	11.22	10.7	9.49	7.93	6.68
Retained Earnings	-118.25	-106.45	-80.98	-70.93	-48.36
Comprehensive Income & Other	9.83	0.02	0.06	0.17	0.23
Total Common Equity	19.1	5.19	29.49	20.84	38.15
Shareholders' Equity	19.1	5.19	29.49	20.84	38.15
Total Liabilities & Equity	28.38	19.13	36.45	23.46	42.25
Total Debt	0.17	-	-	-	0.03
Net Cash (Debt)	24.67	16.98	33.6	20.54	40.35
Net Cash Growth	45.27%	-49.45%	63.60%	-49.11%	7.22%
Net Cash Per Share	0.32	0.24	0.52	0.38	0.81
Filing Date Shares Outstanding	83.38	76.18	69.64	56.3	53.55
Total Common Shares Outstanding	78.22	69.64	69.64	55.65	53.55
Working Capital	23.74	16.21	29.43	20.77	38.04
Book Value Per Share	0.24	0.07	0.42	0.37	0.71
Tangible Book Value	19.04	5.13	29.43	20.77	38.07
Tangible Book Value Per Share	0.24	0.07	0.42	0.37	0.71

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.